Cargando…
Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection
Humoral immunity after SARS-CoV-2 immunization or natural infection is thought to be evanescent. In our study, we aimed to longitudinally characterize the kinetics of antibody titers after dual BNT162b2 immunization or wild-type infection. Vaccinated and recovered individuals displayed distinct anti...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416143/ https://www.ncbi.nlm.nih.gov/pubmed/36016097 http://dx.doi.org/10.3390/vaccines10081210 |
_version_ | 1784776407950295040 |
---|---|
author | Lagousi, Theano Routsias, John Mavrouli, Maria Papadatou, Ioanna Geropeppa, Maria Spoulou, Vana |
author_facet | Lagousi, Theano Routsias, John Mavrouli, Maria Papadatou, Ioanna Geropeppa, Maria Spoulou, Vana |
author_sort | Lagousi, Theano |
collection | PubMed |
description | Humoral immunity after SARS-CoV-2 immunization or natural infection is thought to be evanescent. In our study, we aimed to longitudinally characterize the kinetics of antibody titers after dual BNT162b2 immunization or wild-type infection. Vaccinated and recovered individuals displayed distinct antibody kinetics, as convalescents had detectable RBD-, S1-specific, and neutralizing IgG antibody titers two weeks post-infection that gradually increased longitudinally, while RBD-, S1-specific, and neutralizing IgG were detected in vaccinees after the first dose, increased significantly 3 weeks post the second dose and decreased significantly 4–5 months thereafter. Neutralizing IgG was significantly higher initially in convalescent individuals; however, vaccines displayed significantly higher neutralizing antibodies 4–5 months post the second dose. In both groups, there was a strong negative association between elapsed time and antibody levels. The avidity of anti-RBD antibody titers increased significantly in patients longitudinally, while in vaccinees initially increased, with subsequent decrease, remaining however higher than antibody avidity of recovered individuals at all time-points. Anti-RBD antibodies were strongly correlated with neutralizing and anti-S1 antibodies in both groups at all time-points. This study facilitates our further understanding of immune response to SARS-CoV-2 and vaccines. |
format | Online Article Text |
id | pubmed-9416143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94161432022-08-27 Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection Lagousi, Theano Routsias, John Mavrouli, Maria Papadatou, Ioanna Geropeppa, Maria Spoulou, Vana Vaccines (Basel) Brief Report Humoral immunity after SARS-CoV-2 immunization or natural infection is thought to be evanescent. In our study, we aimed to longitudinally characterize the kinetics of antibody titers after dual BNT162b2 immunization or wild-type infection. Vaccinated and recovered individuals displayed distinct antibody kinetics, as convalescents had detectable RBD-, S1-specific, and neutralizing IgG antibody titers two weeks post-infection that gradually increased longitudinally, while RBD-, S1-specific, and neutralizing IgG were detected in vaccinees after the first dose, increased significantly 3 weeks post the second dose and decreased significantly 4–5 months thereafter. Neutralizing IgG was significantly higher initially in convalescent individuals; however, vaccines displayed significantly higher neutralizing antibodies 4–5 months post the second dose. In both groups, there was a strong negative association between elapsed time and antibody levels. The avidity of anti-RBD antibody titers increased significantly in patients longitudinally, while in vaccinees initially increased, with subsequent decrease, remaining however higher than antibody avidity of recovered individuals at all time-points. Anti-RBD antibodies were strongly correlated with neutralizing and anti-S1 antibodies in both groups at all time-points. This study facilitates our further understanding of immune response to SARS-CoV-2 and vaccines. MDPI 2022-07-29 /pmc/articles/PMC9416143/ /pubmed/36016097 http://dx.doi.org/10.3390/vaccines10081210 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Lagousi, Theano Routsias, John Mavrouli, Maria Papadatou, Ioanna Geropeppa, Maria Spoulou, Vana Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection |
title | Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection |
title_full | Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection |
title_fullStr | Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection |
title_full_unstemmed | Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection |
title_short | Comparative Characterization of Human Antibody Response Induced by BNT162b2 Vaccination vs. SARS-CoV-2 Wild-Type Infection |
title_sort | comparative characterization of human antibody response induced by bnt162b2 vaccination vs. sars-cov-2 wild-type infection |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416143/ https://www.ncbi.nlm.nih.gov/pubmed/36016097 http://dx.doi.org/10.3390/vaccines10081210 |
work_keys_str_mv | AT lagousitheano comparativecharacterizationofhumanantibodyresponseinducedbybnt162b2vaccinationvssarscov2wildtypeinfection AT routsiasjohn comparativecharacterizationofhumanantibodyresponseinducedbybnt162b2vaccinationvssarscov2wildtypeinfection AT mavroulimaria comparativecharacterizationofhumanantibodyresponseinducedbybnt162b2vaccinationvssarscov2wildtypeinfection AT papadatouioanna comparativecharacterizationofhumanantibodyresponseinducedbybnt162b2vaccinationvssarscov2wildtypeinfection AT geropeppamaria comparativecharacterizationofhumanantibodyresponseinducedbybnt162b2vaccinationvssarscov2wildtypeinfection AT spoulouvana comparativecharacterizationofhumanantibodyresponseinducedbybnt162b2vaccinationvssarscov2wildtypeinfection |